FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:2795-2796 December 28, 2006 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Richard A. Walsh. 736 pp., illustrated. Abingdon, England, Informa Healthcare/Taylor & Francis, 2005. $749.95. ISBN 1-84214-248-8.

Twenty years ago, the American Heart Association sponsored a symposium in Boston that constituted the first national meeting focused exclusively on the molecular biology of cardiovascular disease. Other disciplines of medicine had already moved into the molecular era, but this meeting represented a major shift for the field of cardiovascular research. Increasingly, investigators were taking advantage of the new tools afforded them by discoveries in molecular biology to answer important questions about the molecular and cellular mechanisms responsible for the development of cardiovascular disease. In the ensuing 20 years, the development of new technology and its linkage with traditional biochemical . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.